Effective subunit vaccines against an enveloped animal virus.
about
In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.Secretion of the hepatitis B virus surface antigen from mouse cells using an extra-chromosomal eucaryotic vector.Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes.Interactions of Semliki Forest virus spike glycoprotein rosettes and vesicles with cultured cellsChallenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III.Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations.Influenza virosomes as a vaccine adjuvant and carrier system.Influenza virosomes as vaccine adjuvant and carrier system.Interaction of viral envelope glycoproteins with fibronectin.Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins.Properties of monospecific antibodies to the glycoprotein of western equine encephalitis virus.The glycoprotein of measles virus. External radioactive labelling of its carbohydrate and partial characterization of the glycopeptide.Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms.Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms.The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes.
P2860
Q33913314-225942CD-B60D-425B-99AB-AAA1832C3305Q33933483-ECD1AFFD-6536-4A9B-BA7A-537660BFBE16Q34254100-925A0333-0031-4F5D-8F21-142DE1A45239Q36206718-715C71FB-0BA7-4782-AD5A-2F87FDEDAC71Q36832017-72C374D6-2E56-46E5-9714-EA1CCF394E30Q36885076-7385FD92-F5A0-4C2E-ABC9-5C18D13D1937Q36968260-4212D356-8FAD-4112-AFE6-B144936F6E85Q37867100-4BC08AC6-6A36-4187-93B4-8500B62A63C1Q38124062-894DF50E-0ED0-435D-9DE0-1F9B3FBDD744Q40600641-8B8BCF0D-3A87-463F-80B4-2E4309709979Q40611287-72E8C62C-B505-4061-A740-E826F50ACCFBQ41971228-64B76B51-9B75-4528-8728-B1DC68B434A6Q42879540-59610D3C-F007-4D1A-9BA0-7D8ABD2C6E31Q44001894-AA31002C-8699-496A-81C2-CDE06611845DQ44214353-51797226-F66C-4C62-B80E-4469CDD26A89Q45832415-15124408-51D6-4210-9F63-A3B1602B5C05
P2860
Effective subunit vaccines against an enveloped animal virus.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Effective subunit vaccines against an enveloped animal virus.
@en
type
label
Effective subunit vaccines against an enveloped animal virus.
@en
prefLabel
Effective subunit vaccines against an enveloped animal virus.
@en
P2093
P2860
P356
P1433
P1476
Effective subunit vaccines against an enveloped animal virus.
@en
P2093
Helenius A
Kääriäinen L
Pettersson R
Schirrmacher V
P2860
P2888
P304
P356
10.1038/276715A0
P407
P50
P577
1978-12-01T00:00:00Z
P6179
1004919367